Latest Publications

Share:

FDA And TTB Issue Guidance To Increase Hand Sanitizer Production During COVID-19 Outbreak

The Food and Drug Administration and the Alcohol and Tobacco Tax and Trade Bureau (TTB) have both recently issued guidance documents to allow for the increased production of alcohol-based hand sanitizer during the COVID-19...more

FDA Issues Temporary Policy For Food Manufacturers And Importers In Light Of COVID-19 Outbreak

On March 17, 2020, the U.S. Food and Drug Administration (FDA) issued guidance to food manufacturers and importers in response to the COVID-19 pandemic. In the guidance, FDA stated it will temporarily not enforce supplier...more

Coronavirus In FDA-Regulated Industries

Companies directly and indirectly regulated by the U.S. Food and Drug Administration (FDA) face specific challenges separate from other businesses in dealing with the recent outbreak of coronavirus disease 2019 (COVID-19). ...more

Ag-Gag Law Update - Feburary 2020

We have blogged, most recently on January 3, 2020, about the status of so-called “ag-gag” laws. These laws are designed to prevent undercover scrutiny of agricultural operations to uncover cruelty to animals, food safety...more

FDA States CBD Is Not GRAS for Use In Food, Issues More Warning Letters

The U.S. Food and Drug Administration (FDA) issued a press release on the evening of Monday, November 25 concerning its recent enforcement actions and a regulatory decision concerning products that contain cannabidiol (CBD)....more

FDA Announces Criminal Investigations Of Vaping-Related Illnesses

Beginning this summer, the Food and Drug Administration (FDA) through its Office of Criminal Investigations, launched a criminal probe to investigate the vaping-related lung illnesses that have affected over five hundred...more

FDA Warning Letter To CBD Company Provides Many Lessons For Burgeoning Market

The U.S. Food and Drug Administration (“FDA”) issued a Warning Letter, dated July 22, 2019, to Curaleaf, Inc. (“Curaleaf”), a multi-billion dollar market cap company that is publicly traded on the Canadian Securities...more

At Public Meeting, FDA Requests Data On Dosage And Delivery Formats Of CBD And Other Cannabis-Derived Compounds

Friday, the U.S. Food and Drug Administration held a meeting to discuss its regulatory approach to products that contain cannabis and cannabis-derived compounds, including cannabidiol (CBD). The public hearing was intended to...more

Supreme Court Reiterates That Federal Law Preemption For Product Warnings Is A Matter For Judge, Not Jury

On Monday, the United States Supreme Court found that a judge is better suited than a jury to decide if consumers’ tort claims are preempted by federal regulations. In the case, Merck Sharp & Dome, Corp. v. Albreecht, the...more

TTB Follows FDA’s Lead And Prohibits Use Of CBD In Alcoholic Beverages

The Alcohol and Tobacco Tax and Trade Bureau (TTB) recently issued an industry circular which makes clear that cannabidiol (CBD), a product derived from hemp, is not permitted in alcohol beverages. TTB generally consults...more

Clarity At Last? FDA Announces Plans For Meeting On Cannabis-Derived Compounds

On Wednesday, April 3, 2019, the U.S. Food and Drug Administration (FDA) announced plans to hold a meeting to discuss its regulatory approach to products that contain cannabis and cannabis-derived compounds, including...more

36 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide